Who owns the SADA Y-PRIT trademark?

The SADA Y-PRIT trademark is owned by Y-mAbs Therapeutics, Inc.

What is the serial number for SADA Y-PRIT?

The USPTO serial number for SADA Y-PRIT is 98033275.

What is the registration number for SADA Y-PRIT?

SADA Y-PRIT is registered under USPTO registration number 7813863.

SAD

USPTO Trademark Record

REGISTERED

SADA Y-PRIT

Q: What class is the SADA Y-PRIT trademark registered in?

The SADA Y-PRIT trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 98033275·Reg 7813863·Filed Jun 08, 2023

Owner Y-mAbs Therapeutics, Inc

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

SADA Y-PRIT (Serial No. 98033275), Registration No. 7813863, is a registered US trademark filed on Jun 08, 2023 by Y-mAbs Therapeutics, Inc. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: June 03, 2031

Mark Intelligence

SADA Y-PRIT (Reg. #7813863) is a registered US trademark that has been protecting its owner, Y-mAbs Therapeutics, Inc, since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 2 opposition proceedings during prosecution.

FILED

Jun 08, 2023

SERIAL

98033275

REG#

7813863

REGISTERED

Jun 03, 2025

Owner

Applicant

Y-mAbs Therapeutics, Inc

Entity

Corporation

State

Address

230 Park Avenue, Suite 3350, New York, NY, 10169

Country

Attorney

NameAndrew N. Spivak

Law firm

Andrew N. Spivak MOSAIC LEGAL GROUP, PLLC

Docket

26418

Address

5185 MACARTHUR BOULEVARD, NW, SUITE 350, WASHINGTON, DC 20016-3341, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 08, 2023

Serial Number98033275

Registration No.7813863

Registration DateJun 03, 2025

Status DateJun 03, 2025

Published for OppositionApr 15, 2025

Mark TypeStandard characters

Attorney Docket26418

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 2× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

33 events

REGISTERED-PRINCIPAL REGISTER

Jun 03, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 03, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Apr 15, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 15, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 09, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

CASE RETURNED TO EXAMINATION

Jan 25, 2025

CASE RETURNED TO EXAMINATION

Dec 23, 2024

CASE RETURNED TO EXAMINATION

REINSTATED

Dec 23, 2024

REINSTATED

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

Dec 23, 2024

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Dec 23, 2024

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

CASE RETURNED TO EXAMINATION

Dec 23, 2024

CASE RETURNED TO EXAMINATION

ABANDONMENT - NO USE STATEMENT FILED

Dec 23, 2024

ABANDONMENT - NO USE STATEMENT FILED

PETITION INQUIRY LETTER ISSUED

Dec 19, 2024

PETITION INQUIRY LETTER ISSUED

TEAS RESPONSE TO PETITION INQUIRY LETTER

Dec 19, 2024

TEAS RESPONSE TO PETITION INQUIRY LETTER

ASSIGNED TO PETITION STAFF

Dec 16, 2024

ASSIGNED TO PETITION STAFF

NOTICE OF ALLOWANCE CANCELLED

Nov 14, 2024

NOTICE OF ALLOWANCE CANCELLED

44(e) PETITION - RECEIVED

Jun 20, 2024

44(e) PETITION - RECEIVED

TEAS POST PUBLICATION AMENDMENT RECEIVED

Jun 20, 2024

TEAS POST PUBLICATION AMENDMENT RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 04, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 03, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

May 03, 2024

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

May 03, 2024

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 14, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 19, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 19, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 30, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 11, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Aug 09, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Aug 09, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 09, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Aug 09, 2023

EXAMINER'S AMENDMENT ENTERED

ASSIGNED TO EXAMINER

Aug 01, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 12, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SADA Y-PRIT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Y-mAbs Therapeutics, Inc

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Andrew N. Spivak

Resources

Company